The anti‐obesity effects of CM are mediated through the mitogen‐activated protein kinase (MAPK) and Nuclear Factor Kappa B (NF‐κB) signaling pathways, resulting in a decrease in inflammation, promoting cellular protection, and potentially aiding in obesity reduction. The gene discussed is NFKB1; the disease is obesity disorder.